142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

308483
A Statewide Healthcare Worker Influenza Vaccination Policy: Strategies to Overcome Implementation Barriers

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Natasha Massoudi, MPH , JSI Research and Training Institute, Inc., Boston, MA
Peter Freeman, MPH , JSI Research and Training Institute, Inc., Boston, MA
Liesl Bradford, MS , JSI Research and Training Institute, Inc., Boston, MA
Donna Dube, MS, RN , Independent healthcare consultant, RI
Hanna Kim, PhD , Division of Community, Family Health & Equity, Rhode Island Department of Health, Providence, RI
Kristi Paiva, MPH , Division of Community, Family Health & Equity, Rhode Island Department of Health, Providence, RI
Patricia Raymond, RN, MPH , Division of Community, Family Health & Equity, Rhode Island Department of Health, Providence, RI
Terry Greene, M.S. , Health Services Division, JSI Research & Training Institute, Boston, MA
Rachel Kohn, MSW, MPH , JSI Research & Training Institute, Inc., Bow, NH
Introduction

In October 2012, the Rhode Island Department of Health (RI HEALTH) enacted a statewide policy requiring healthcare workers (HCWs) to receive or formally decline an influenza vaccination. The policy included a mandate that unvaccinated workers had to wear a mask during patient contact if influenza was declared widespread.

Methods

RI HEALTH contracted JSI Research & Training Institute, Inc. to conduct semi-structured key informant interviews in order to evaluate the policy implementation. Key informants from healthcare facilities and health policy stakeholder organizations were asked to provide feedback on their experiences with the policy. Interviews focused on the policy’s impact, compliance issues, and barriers to implementation and strategies to overcome them.

Results

Barriers to policy implementation included HCWs’ resistant attitudes towards vaccinations, challenges in tracking compliance, and strains on facility resources. Strategies to address these barriers at the facility-level included unique staff education campaigns and dynamic monitoring systems to track staff compliance to the policy. Macro-level recommendations included the development of a formalized, statewide definition of a “HCW” and the continuation of RI HEALTH’s strong efforts to engage community stakeholder buy-in for the policy.

Discussion and Conclusion

RI HEALTH experienced an increase in HCW influenza vaccination rates, despite encountering barriers to policy implementation. Healthcare facilities and health policy stakeholder organizations adopted new and adapted pre-existing mechanisms to meet compliance requirements and enhance educational efforts. Findings also suggest that Rhode Island’s experience could be used as model for other states planning or considering implementation of a similar policy.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Occupational health and safety
Protection of the public in relation to communicable diseases including prevention or control
Public health or related public policy

Learning Objectives:
Describe barriers to implementing a statewide influenza vaccination policy Describe strategies to increase compliance to a statewide influenza vaccination policy Discuss recommendations for other states interested in planning or implementing a statewide influenza vaccination policy

Keyword(s): Occupational Health and Safety, Policy/Policy Development

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been providing technical assistance and program evaluation services for over 17 years to local, state and federal clients with a primary focus on health risk behavior prevention and treatment services in Massachusetts and New Hampshire.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.